Novavax, Moderna, Pfizer, Gilead and Vir Biotechnology

DaGeek

For Immediate Release

Chicago, IL – May 27, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Novavax NVAX, Moderna MRNA, Pfizer PFE, Gilead GILD and Vir Biotechnology VIR.

Here are highlights from Tuesday’s Analyst Blog:

Coronavirus Vaccine Efforts Continue: Novavax (NVAX) and More

Novavax announced that it has enrolled the first set of patients in a phase I/II clinical study of its coronavirus vaccine candidate, NVX-CoV2373. The study is being conducted in two portions phase I and II. The phase I portion will enroll approximately 130 healthy participants, aged 18 to 59 at two sites in Australia. Preliminary data from the phase I portion of the study is expected in July and the phase II portion is expected to

Read More . . .

Subscribe US Now